FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2172628409> ?p ?o ?g. }

• W2172628409 abstract "From December 1982 to January 1986, 57 patients received allogeneic bone marrow transplantation as therapy for Philadelphia chromosome (Ph') positive chronic myelogenous leukemia (CML). All patients were prepared for transplantation with cyclophosphamide 60 mg/kg (day -6, -5) and fractionated total body irradiation, 165 cGy twice daily (day -4, -3, -2, -1) and received major histocompatibility (MHC) matched donor marrow (day 0). All patients received graft-v-host disease (GVHD) prophylaxis with methotrexate, prednisone, and either antithymocyte globulin (ATG) (55 patients) or OKT3 infusion (two patients). The projected survival of 29 chronic phase patients is 64% (95% confidence interval [Cl] 42% to 86%); and of 28 accelerated phase patients, 30% (95% Cl, 12% to 48%) at 30 months (P = .005). Multivariate regression analysis of pretransplant patient characteristics demonstrated that the presence of chronic phase and age less than 30 years were the only prognostic features studied that independently predicted survival. No evidence of persistent or recurrent disease has occurred in chronic phase patients; however, reappearance of the Ph' was observed in seven accelerated-phase patients, and hematologic relapse occurred in three of these seven patients. The incidence of grade II to IV acute GVHD is 63% (95% Cl, 50% to 76%) at 100 days, and that of extensive chronic GVHD is 53% (95% Cl, 33% to 74%) at 30 months. The median Karnofsky activity assessment of survivors is 100% (range, 60% to 100%), and all activity assessments less than 100% can be attributed to complications of GVHD. Bone marrow transplantation therapy for CML after preparation with cyclophosphamide and fractionated total body irradiation results in a high proportion of disease-free survival in chronic-phase patients. Survival in accelerated phase is significantly worse and is associated with relapse. GVHD has emerged as a significant cause of morbidity and mortality in this study." @default.
• W2172628409 created "2016-06-24" @default.
• W2172628409 creator A5004300224 @default.
• W2172628409 creator A5023116107 @default.
• W2172628409 creator A5043649821 @default.
• W2172628409 creator A5046039221 @default.
• W2172628409 creator A5058533219 @default.
• W2172628409 creator A5060278446 @default.
• W2172628409 creator A5061379753 @default.
• W2172628409 creator A5070132319 @default.
• W2172628409 creator A5071051461 @default.
• W2172628409 creator A5091177221 @default.
• W2172628409 date "1987-07-01" @default.
• W2172628409 modified "2023-09-25" @default.
• W2172628409 title "Therapy of chronic myelogenous leukemia with allogeneic bone marrow transplantation." @default.
• W2172628409 cites W1530764705 @default.
• W2172628409 cites W1580788756 @default.
• W2172628409 cites W175581909 @default.
• W2172628409 cites W1908565253 @default.
• W2172628409 cites W193514409 @default.
• W2172628409 cites W1963662819 @default.
• W2172628409 cites W1964099284 @default.
• W2172628409 cites W1979300931 @default.
• W2172628409 cites W1987088372 @default.
• W2172628409 cites W1990062674 @default.
• W2172628409 cites W2019721088 @default.
• W2172628409 cites W2020932589 @default.
• W2172628409 cites W2022718327 @default.
• W2172628409 cites W2042568970 @default.
• W2172628409 cites W2043307123 @default.
• W2172628409 cites W2050642909 @default.
• W2172628409 cites W2066297886 @default.
• W2172628409 cites W2067480394 @default.
• W2172628409 cites W2086602173 @default.
• W2172628409 cites W2096779083 @default.
• W2172628409 cites W2117983550 @default.
• W2172628409 cites W2122455557 @default.
• W2172628409 cites W2337969406 @default.
• W2172628409 cites W2398072817 @default.
• W2172628409 cites W2400870116 @default.
• W2172628409 cites W240979114 @default.
• W2172628409 cites W2410486943 @default.
• W2172628409 cites W2411546670 @default.
• W2172628409 cites W2444516118 @default.
• W2172628409 cites W285482863 @default.
• W2172628409 doi "https://doi.org/10.1200/jco.1987.5.7.1033" @default.
• W2172628409 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/3298558" @default.
• W2172628409 hasPublicationYear "1987" @default.
• W2172628409 type Work @default.
• W2172628409 sameAs 2172628409 @default.
• W2172628409 citedByCount "60" @default.
• W2172628409 countsByYear W21726284092012 @default.
• W2172628409 countsByYear W21726284092013 @default.
• W2172628409 countsByYear W21726284092015 @default.
• W2172628409 countsByYear W21726284092018 @default.
• W2172628409 crossrefType "journal-article" @default.
• W2172628409 hasAuthorship W2172628409A5004300224 @default.
• W2172628409 hasAuthorship W2172628409A5023116107 @default.
• W2172628409 hasAuthorship W2172628409A5043649821 @default.
• W2172628409 hasAuthorship W2172628409A5046039221 @default.
• W2172628409 hasAuthorship W2172628409A5058533219 @default.
• W2172628409 hasAuthorship W2172628409A5060278446 @default.
• W2172628409 hasAuthorship W2172628409A5061379753 @default.
• W2172628409 hasAuthorship W2172628409A5070132319 @default.
• W2172628409 hasAuthorship W2172628409A5071051461 @default.
• W2172628409 hasAuthorship W2172628409A5091177221 @default.
• W2172628409 hasConcept C126322002 @default.
• W2172628409 hasConcept C141071460 @default.
• W2172628409 hasConcept C2776694085 @default.
• W2172628409 hasConcept C2776755627 @default.
• W2172628409 hasConcept C2776960273 @default.
• W2172628409 hasConcept C2778461978 @default.
• W2172628409 hasConcept C2778720950 @default.
• W2172628409 hasConcept C2778880498 @default.
• W2172628409 hasConcept C2780007613 @default.
• W2172628409 hasConcept C2781059491 @default.
• W2172628409 hasConcept C2911091166 @default.
• W2172628409 hasConcept C71924100 @default.
• W2172628409 hasConcept C90924648 @default.
• W2172628409 hasConceptScore W2172628409C126322002 @default.
• W2172628409 hasConceptScore W2172628409C141071460 @default.
• W2172628409 hasConceptScore W2172628409C2776694085 @default.
• W2172628409 hasConceptScore W2172628409C2776755627 @default.
• W2172628409 hasConceptScore W2172628409C2776960273 @default.
• W2172628409 hasConceptScore W2172628409C2778461978 @default.
• W2172628409 hasConceptScore W2172628409C2778720950 @default.
• W2172628409 hasConceptScore W2172628409C2778880498 @default.
• W2172628409 hasConceptScore W2172628409C2780007613 @default.
• W2172628409 hasConceptScore W2172628409C2781059491 @default.
• W2172628409 hasConceptScore W2172628409C2911091166 @default.
• W2172628409 hasConceptScore W2172628409C71924100 @default.
• W2172628409 hasConceptScore W2172628409C90924648 @default.
• W2172628409 hasLocation W21726284091 @default.
• W2172628409 hasLocation W21726284092 @default.
• W2172628409 hasOpenAccess W2172628409 @default.
• W2172628409 hasPrimaryLocation W21726284091 @default.
• W2172628409 hasRelatedWork W2026872025 @default.
• W2172628409 hasRelatedWork W2038187203 @default.
• W2172628409 hasRelatedWork W2067889013 @default.
• W2172628409 hasRelatedWork W206879038 @default.

• next